The researchers note that although the FDA approved the prescription of a range of apps that transmit sensitive health data, the behind-the-scenes practices of these apps are “understudied.” They examined 211 diabetes apps and randomly sampled 65 of them for close analysis of data-transmission practices.

Shoshana Zuboff, The Age of Surveillance Cap…, loc. 780